Poster presentation at the 2nd ASPIC International Congress. 28-29 April, 2016. Porto. Portugal. We are pleased to inform you that Enrique De Alava team from Hospital Virgen del Rocío, Sevilla, Spain,
New publication at the ASPIC 2016
Oncomatryx at BIO-EUROPE Spring 2016
BIO-EUROPE Spring 2016. April 4-6, 2016. Stockholm, Sweden. Oral Presentation: “Tumor microenvironment - targeted biopharmaceuticals”. Laureano Simón, PhD If you are also attending Bio-Europe and would like to meet us please fill this
World ADC Berlin
6th World ADC Summit. 8th-10th February 2016. Berlin (Germany). ONCOMATRYX will be attending World ADC Berlin. Poster Presentation: “OMTX705, a powerful stroma-targeting ADC to treat invasive tumors” by Myriam Fabre, PhD. If you
TV INTERVIEW -EITB-
Oncomatryx Diagnostics Area director, Saioa Dominguez, interviewed at Basque National Television.
Starten Forschungskooperation
10.12.2012 12:33 Uni Stuttgart und Oncomatrix starten Forschungskooperation Andrea Mayer-Grenu Abteilung Hochschulkommunikation Universität Stuttgart Neuer Krebsmedikamente für die Behandlung metastasierender Tumore Das spanische Biopharmazeutik-Unternehmen Oncomatrix und die Universität Stuttgart haben
Spanish Company Oncomatrix Develops a Test
Spanish Company Oncomatrix Develops a Test That Detects Whether a Breast Cancer Disease Will Develop Metastasis 6/26/2013 9:28:31 AM Get the latest biotech news where you want it. Sign up